TrialEuropean heart journal2021

Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.

Alice M Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.